The Kyoto Encyclopedia of Genes and Genomes (KEGG) and Gene Ontology (GO) enrichment analyses were utilized to investigate the underlying molecular mechanisms of CDK6. Exploring the clinical features of CDK6 can help us target AML synergistically with other potential therapies and reduce the frequency of resistance. The gene discussed is CDK6; the disease is acute myeloid leukemia.